Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. usa massachusetts
  4. antibiotic use
Show results for
Products
Applications

Companies


Refine by
Locations
Back to All Locations

  • USA
  • Massachusetts
Brands

  • finch
  • seres
  • t2resistance
Applications

  • Microbiome Therapeutics for Clinical Trials
  • Microbiome Therapeutics for Patients and Physicians

Antibiotic Use Equipment Supplied In Usa Massachusetts

3 equipment items found
In MassachusettsAvailable In MassachusettsNear Massachusetts

Finch - Model CP101 - Microbiome Therapeutics for Recurrent C. Difficile Infection (CDI)

Finch - Model CP101 - Microbiome Therapeutics for Recurrent C. Difficile Infection (CDI)

Manufactured by:Finch Therapeutics Group, Inc.   based inSomerville, MASSACHUSETTS (USA)
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most urgent antibiotic resistant threats and the most common cause of healthcare associated infection in the United ...
CONTACT SUPPLIER

T2Resistance - Blood Detection Panel for Antimicrobial Resistance Markers

T2Resistance - Blood Detection Panel for Antimicrobial Resistance Markers

by:T2 Biosystems, Inc.   based inLexington, MASSACHUSETTS (USA)
The first direct-from-blood detection of resistance markers: The T2Resistance® Panel is designed for the direct-from-blood detection of antibiotic resistance genes associated with sepsis-causing pathogens. The Panel detects many of the resistance mechanisms described in the 2013 CDC Urgent Threat list. In 2019, the FDA granted “Breakthrough Device” designation for ...
CONTACT SUPPLIER

Seres - Model SER-155 - Investigational, Oral, Rationally Designed, Fermented Microbiome Therapeutic

Seres - Model SER-155 - Investigational, Oral, Rationally Designed, Fermented Microbiome Therapeutic

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-155 is an investigational, oral, rationally designed, fermented microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bacteremia, and graft versus host disease (GvHD) in immunocompromised patients, including patients receiving allogeneic hematopoietic stem cell transplantation ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT